Genomics

Dataset Information

Simultaneous treatment of castration-resistant prostate cancer cells with the DNA Demethylating Agent Decitabine and S-adenosylmethionine leads to synergistic anti- cancer effects.


ABSTRACT: Simultaneous treatment of castration-resistant prostate cancer cells with the DNA Demethylating Agent Decitabine and S-adenosylmethionine leads to synergistic anti- cancer effects.

PROVIDER: PRJNA1105942 | ENA |

REPOSITORIES: ENA